Dietary weight loss-induced improvements in metabolic function are enhanced by exercise in people with obesity and prediabetes.
Joseph W BealsBrandon D KayserGordon I SmithGeorge G SchweitzerKyleigh KirbachMonica L KearneyJun YoshinoGibraan RahmanRob KnightBruce W PattersonSamuel KleinPublished in: Nature metabolism (2023)
The additional therapeutic effects of regular exercise during a dietary weight loss program in people with obesity and prediabetes are unclear. Here, we show that whole-body (primarily muscle) insulin sensitivity (primary outcome) was 2-fold greater (P = 0.006) after 10% weight loss induced by calorie restriction plus exercise training (Diet+EX; n = 8, 6 women) than 10% weight loss induced by calorie restriction alone (Diet-ONLY; n = 8, 4 women) in participants in two concurrent studies. The greater improvement in insulin sensitivity was accompanied by increased muscle expression of genes involved in mitochondrial biogenesis, energy metabolism and angiogenesis (secondary outcomes) in the Diet+EX group. There were no differences between groups in plasma branched-chain amino acids or markers of inflammation, and both interventions caused similar changes in the gut microbiome. Few adverse events were reported. These results demonstrate that regular exercise during a diet-induced weight loss program has profound additional metabolic benefits in people with obesity and prediabetes.Trial Registration: ClinicalTrials.gov (NCT02706262 and NCT02706288).
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- gastric bypass
- physical activity
- high intensity
- skeletal muscle
- oxidative stress
- glycemic control
- weight gain
- polycystic ovary syndrome
- quality improvement
- resistance training
- clinical trial
- poor prognosis
- amino acid
- radiation therapy
- pregnancy outcomes
- metabolic syndrome
- vascular endothelial growth factor
- adipose tissue
- intellectual disability
- high glucose
- wound healing
- cervical cancer screening
- body composition
- locally advanced
- breast cancer risk
- case control
- double blind